Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kloog

Showing results (111-120 of 538) with videos related to

Pageof 54
Sort By:
Molecular Cancer Therapeutics|June 2, 2007
Suppression of lung cancer tumor growth in a nude mouse model by the Ras inhibitor salirasib (farnesylthiosalicylic acid)Adi Zundelevich, Galit Elad-Sfadia, Ronit Haklai, et al.
The Annals of Applied Statistics|December 9, 2017
Spatial Multiresolution Analysis of the Effect of PM<sub>2.5</sub> on Birth WeightsJoseph Antonelli, Joel Schwartz, Itai Kloog, et al.
Oncotarget|March 27, 2013
Growth of poorly differentiated endometrial carcinoma is inhibited by combined action of medroxyprogesterone acetate and the Ras inhibitor SalirasibRaya Faigenbaum, Roni Haklai, Gilad Ben-Baruch, et al.
Cellular Signalling|September 1, 2004
Ras inhibition leads to transcriptional activation of p53 and down-regulation of Mdm2: two mechanisms that cooperatively increase p53 function in colon cancer cellsJulius Halaschek-Wiener, Volker Wacheck, Yoel Kloog, et al.
Plos One|October 3, 2013
Disrupting the oncogenic synergism between nucleolin and Ras results in cell growth inhibition and cell deathSari Schokoroy, Dolly Juster, Yoel Kloog, et al.
Molecular Cancer Therapeutics|August 5, 2010
Galectin-3 promotes chronic activation of K-Ras and differentiation block in malignant thyroid carcinomasRan Levy, Meital Grafi-Cohen, Zaki Kraiem, et al.
Biochemical and Biophysical Research Communications|December 31, 1980
Enzymatic carboxymethylation of the nicotinic acetylcholine receptorY Kloog, D Flynn, A R Hoffman, et al.
Biochimica Et Biophysica Acta|August 14, 1999
Stimulation of neutrophils by prenylcysteine analogs: Ca(2+) release and influxD Tisch-Idelson, M Sharabani, Y Kloog, et al.
Cellular and Molecular Neurobiology|April 1, 1994
Lack of correlation between 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and lovastatin resistance in nerve growth factor treated PC-12 cellsM Marom, G Ben-Baruch, J Roitelman, et al.
Life Sciences|September 15, 1975
Properties of solubilized prostaglandin synthetase from sheep vesicular glandsA Raz, Y Kloog, E Perel, et al.
Pageof 54

Showing results (111-120 of 538) with videos related to

Sort By:
Pageof 54
Molecular Cancer Therapeutics|June 2, 2007
Suppression of lung cancer tumor growth in a nude mouse model by the Ras inhibitor salirasib (farnesylthiosalicylic acid)Adi Zundelevich, Galit Elad-Sfadia, Ronit Haklai, et al.
The Annals of Applied Statistics|December 9, 2017
Spatial Multiresolution Analysis of the Effect of PM<sub>2.5</sub> on Birth WeightsJoseph Antonelli, Joel Schwartz, Itai Kloog, et al.
Oncotarget|March 27, 2013
Growth of poorly differentiated endometrial carcinoma is inhibited by combined action of medroxyprogesterone acetate and the Ras inhibitor SalirasibRaya Faigenbaum, Roni Haklai, Gilad Ben-Baruch, et al.
Cellular Signalling|September 1, 2004
Ras inhibition leads to transcriptional activation of p53 and down-regulation of Mdm2: two mechanisms that cooperatively increase p53 function in colon cancer cellsJulius Halaschek-Wiener, Volker Wacheck, Yoel Kloog, et al.
Plos One|October 3, 2013
Disrupting the oncogenic synergism between nucleolin and Ras results in cell growth inhibition and cell deathSari Schokoroy, Dolly Juster, Yoel Kloog, et al.
Molecular Cancer Therapeutics|August 5, 2010
Galectin-3 promotes chronic activation of K-Ras and differentiation block in malignant thyroid carcinomasRan Levy, Meital Grafi-Cohen, Zaki Kraiem, et al.
Biochemical and Biophysical Research Communications|December 31, 1980
Enzymatic carboxymethylation of the nicotinic acetylcholine receptorY Kloog, D Flynn, A R Hoffman, et al.
Biochimica Et Biophysica Acta|August 14, 1999
Stimulation of neutrophils by prenylcysteine analogs: Ca(2+) release and influxD Tisch-Idelson, M Sharabani, Y Kloog, et al.
Cellular and Molecular Neurobiology|April 1, 1994
Lack of correlation between 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and lovastatin resistance in nerve growth factor treated PC-12 cellsM Marom, G Ben-Baruch, J Roitelman, et al.
Life Sciences|September 15, 1975
Properties of solubilized prostaglandin synthetase from sheep vesicular glandsA Raz, Y Kloog, E Perel, et al.
Pageof 54